United States - English - NLM (National Library of Medicine)

merck sharp & dohme llc - streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen (unii: 54ec0se5pz) (streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen - unii:54ec0se5pz), streptococcus pneumoniae type 3 capsular polysaccharide diphtheria crm197 protein conjugate antigen (unii: 2vf3v7175u) (streptococcus pneumoniae type 3 capsular polysaccharide diphtheria crm197 protein conjugate antigen - unii:2vf3v7175u), streptococcus pneumoniae type - vaxneuvance™ is indicated for active immunization for the prevention of invasive disease caused by streptococcus pneumoniae serotypes 1, 3, 4, 5, 6a, 6b, 7f, 9v, 14, 18c, 19a, 19f, 22f, 23f and 33f in individuals 6 weeks of age and older. do not administer vaxneuvance to individuals with a severe allergic reaction (e.g., anaphylaxis) to any component of vaxneuvance or to diphtheria toxoid. [see description (11).] risk summary all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. there are no adequate and well-controlled studies of vaxneuvance in pregnant women. available data on vaxneuvance administered to pregnant women are insufficient to inform vaccine-associated risks in pregnancy. developmental toxicity studies have been performed in female rats administered a human dose of vaxneuvance on four

European Union - English - EMA (European Medicines Agency)

biomarin international limited - cerliponase alfa - neuronal ceroid-lipofuscinoses - other alimentary tract and metabolism products, - brineura is indicated for the treatment of neuronal ceroid lipofuscinosis type 2 (cln2) disease, also known as tripeptidyl peptidase 1 (tpp1) deficiency,

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - pregabalin, quantity: 25 mg - capsule, hard - excipient ingredients: purified talc; titanium dioxide; gelatin; pregelatinised maize starch; sodium lauryl sulfate; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - neuroccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,neuroccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - pregabalin, quantity: 300 mg - capsule, hard - excipient ingredients: gelatin; purified talc; sodium lauryl sulfate; purified water; titanium dioxide; pregelatinised maize starch; iron oxide red; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - neuroccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,neuroccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - pregabalin, quantity: 300 mg - capsule, hard - excipient ingredients: gelatin; purified talc; pregelatinised maize starch; titanium dioxide; iron oxide red; sodium lauryl sulfate; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - neuroccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,neuroccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - pregabalin, quantity: 75 mg - capsule, hard - excipient ingredients: gelatin; titanium dioxide; iron oxide red; sodium lauryl sulfate; purified talc; purified water; pregelatinised maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - neuroccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,neuroccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - pregabalin, quantity: 75 mg - capsule, hard - excipient ingredients: gelatin; pregelatinised maize starch; titanium dioxide; purified talc; iron oxide red; sodium lauryl sulfate; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - neuroccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,neuroccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - pregabalin, quantity: 25 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; purified water; purified talc; gelatin; titanium dioxide; pregelatinised maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - neuroccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,neuroccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - pregabalin, quantity: 150 mg - capsule, hard - excipient ingredients: titanium dioxide; gelatin; purified talc; sodium lauryl sulfate; purified water; pregelatinised maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - neuroccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,neuroccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - pregabalin, quantity: 150 mg - capsule, hard - excipient ingredients: gelatin; sodium lauryl sulfate; purified water; titanium dioxide; purified talc; pregelatinised maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - neuroccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,neuroccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.